Aesthetic Dermatology at Akumentis brings together advanced biomolecular science and globally trusted innovations to support skin and hair vitality. Through strategic in-licensing with Caregen, a global leader in peptide-based biotechnology, Akumentis introduces next-generation aesthetic solutions designed for visible, confident outcomes.
This portfolio reflects precision science, clinical credibility, and evolving aesthetic expectations.
Modern aesthetic care is no longer about surface correction alone—it is about restoring structure, strength, and function at a cellular level. Akumentis’ aesthetic dermatology offerings are built around bioactive formulations that support regeneration, resilience, and long-term tissue health.
Each solution is designed to integrate seamlessly into professional aesthetic protocols.
Formulations designed to activate natural repair pathways, supporting skin renewal, recovery, and structural integrity from within.
Advanced bioactive compounds that reinforce skin resilience, elasticity, and barrier function beyond surface aesthetics.
Clinically aligned solutions developed to integrate seamlessly into professional aesthetic and dermatology treatment protocols.
The Aesthetic Dermatology portfolio introduced by Akumentis is guided by the scientific legacy of Dr. Chung, Founder & CEO of Caregen, and a globally recognised authority in peptide-based biotechnology.
With decades of research dedicated to biomimetic peptides and regenerative science, Dr. Chung has played a pivotal role in shaping modern aesthetic and dermatological innovations. His work bridges molecular biology and clinical aesthetics, enabling formulations that support skin and hair health at a cellular level.
Through our collaboration with Caregen, Akumentis offers a curated range of internationally recognised aesthetic products:
Advanced injectable solutions supporting scalp vitality and hair strength.
Next-generation dermal fillers for structure, volume, and refinement.
Targeted formulations improving skin texture and firmness.
Clinically oriented scalp and hair care focused on follicular support.
Daily-use formulations supporting scalp comfort and nourishment.
Intensive care solutions enhancing hair fibre strength and hydration.
Concentrated topical formulations aligned with advanced skin protocols.
Akumentis approaches aesthetic dermatology with a strong emphasis on clinical relevance and practitioner confidence.
Every product is backed by advanced research in peptides, biomimetics, and regenerative science.
Internationally established solutions adapted thoughtfully for Indian aesthetic practice.
Formulations and protocols aligned with dermatologists, aesthetic physicians, and clinics.
Aesthetic Dermatology at Akumentis emphasises sustained skin and hair health rather than short-term visual change. The portfolio supports structured treatment plans that evolve with patient needs, promoting confidence through consistency and care.
Caregen’s expertise in peptide technology and regenerative formulations complements Akumentis’ commitment to quality, compliance, and responsible market introduction.
Together, this partnership delivers:
Unlike short-term pain solutions, Akuwin therapies are developed to support the full recovery journey.

Global innovations introduced through rigorous evaluation.

Designed for real-world aesthetic workflows.

Supporting the next phase of dermatology-led aesthetic care.
Dignissim quisque aliquam facilisi neque dolor cras. Hac ridiculus felis in sapien phasellus maximus facilisi.
Akumentis’ portfolio is built on advanced biomolecular science, focusing on cellular regeneration and biological skin strength rather than surface-level correction. Each solution is designed to support long-term tissue health with clinically credible, bioactive formulations.
Through strategic in-licensing with Caregen, a global leader in peptide-based biotechnology, Akumentis introduces next-generation formulations developed using biomimetic peptides. These innovations are backed by decades of research and are trusted worldwide in professional aesthetic practice.
Yes. All formulations are developed to be protocol-ready, allowing seamless integration into professional dermatology and aesthetic treatment plans while maintaining clinical alignment and consistency in outcomes.
Peptide-based bioactives work by activating natural repair and regeneration pathways within the skin and hair tissue. This supports structural integrity, resilience, elasticity, and long-term vitality—addressing the biological foundation of aesthetic health.
Akumentis Healthcare is one of the fastest-growing pharmaceutical companies in India, with its presence across multiple therapeutic areas
10.00 am - 07.00 pm